Mineralys Therapeutics, Inc. · NASDAQ:MLYS
Catalys Pacific Fund, LP reported a 10.10% stake in Mineralys Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 13, 2026
Catalys Pacific Fund, LP reported a 10.10% stake in Mineralys Therapeutics, Inc., 8,002,738 shares, as a passive investor on Dec 31, 2025. Filed Feb 13, 2026 (Schedule 13G/A).
- Stake
- 10.10%
- Shares
- 8,002,738
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Catalys Pacific Fund, LP | 10.10% | 8,002,738 |
| Catalys Pacific Fund GP, LP | 10.10% | 8,002,738 |
| Catalys Pacific, LLC | 10.10% | 8,002,738 |
| Brian Taylor Slingsby | 10.10% | 8,002,738 |
Source
Related
- Mineralys Therapeutics, Inc.
- Catalys Pacific Fund, LP
- Mineralys Therapeutics, Inc. shareholders
- Schedule 13G/A · Catalys Pacific Fund, LP · Aug 14, 2025
- Form 4 · Peterson Kristine · Oct 20, 2026
- Form 4 · Coats Lonnel · Oct 20, 2026
- Form 4 · Congleton Jon · Oct 2, 2026
- Form 4 · Slingsby Brian Taylor · Sep 24, 2026
- Form 4 · Warren Eric · Sep 22, 2026